Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keppra IV for Motor Fluctuations in Parkinson's Disease
NCT00584025Phase 4Withdrawn
- Sponsor
- University of South Florida
- Start
- Dec 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Keppra IV with Placebo (2 arms). Primary endpoint: Abnormal Involuntary Movements Scale at 15 minutes. Planned start Dec 2007; status: withdrawn.
02
Drugs
levetiracetam
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00584025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584025.